R. Rorig

ASP2151 for the treatment of genital herpes: a randomized, double-blind, placebo- and valacyclovir-controlled, dose-finding study.

A. Wald, S. Tyring, S. Dhadda, 2012, Journal of Infectious Diseases.

Patient preferences when searching for clinical trials and adherence of study records to ClinicalTrials.gov guidance in key registry data fields

Anna Ellsworth, R. Rorig, T. Schindler, 2020, PloS one.

ASP 2151 for the Treatment of Genital Herpes : A Randomized , Double-Blind , Placebo-and Valacyclovir-Controlled , Dose-Finding Study

A. Wald, S. Tyring, S. Dhadda, 2012 .

Linsitinib (OSI-906) versus placebo for patients with locally advanced or metastatic adrenocortical carcinoma: a double-blind, randomised, phase 3 study.

T. Choueiri, E. Baudin, M. Fassnacht, 2015, The Lancet. Oncology.

ASP2151 for the treatment of genital herpes: a randomized, double-blind, placebo- and valacyclovir-controlled, dose-finding study.

A. Wald, S. Tyring, S. Dhadda, 2012, The Journal of infectious diseases.